Pulsenmore Secures CE Mark for Home Ultrasound in Fertility Care
PLSM is trading near its 52-week low of $2.37 (10% above the low).
Summary
Pulsenmore completed CE European registration for its home ultrasound system for fertility monitoring, marking its second product authorized in Europe and first expansion beyond prenatal care.
Key Events · Product Development and Regulatory · PLSM
-
CE Registration Completed
Pulsenmore FC home ultrasound system for follicular monitoring received CE European registration under the Medical Device Regulation (MDR), enabling marketing and sales across European markets.
-
Expansion Beyond Prenatal Care
This is Pulsenmore's second product authorized in Europe and its first expansion into fertility care, targeting the 1.15M+ assisted reproduction treatment cycles reported across Europe in 2023.
-
Clinical Validation Published
A clinical study at Rabin Medical Center showed high agreement between home ultrasound scans and in-clinic examinations, published in the peer-reviewed Journal of Medical Internet Research (JMIR).
-
Existing Commercial Foundation
In Israel, the system has Ministry of Health approval and a commercial agreement with Clalit Health Services signed in January 2026, providing a reference for European commercialization.
Analysis · PLSM · Industrial Applications And Services
Pulsenmore has completed CE European registration for Pulsenmore FC, its home ultrasound system for follicular monitoring during IVF and fertility preservation. This is the company's second product authorized in Europe and its first move beyond prenatal care into the broader women's health market. The registration enables commercial sales across European markets, building on an existing commercial agreement with Clalit Health Services in Israel. For a company with H1 2026 revenue of only ~$2M, opening a new product category in a large European fertility market represents a meaningful expansion opportunity, though commercialization and revenue generation remain unproven.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLSM was trading at $2.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $15.9M. The 52-week trading range was $2.37 to $12.97. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.